azathioprine has been researched along with Berger Disease in 45 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirty-four patients experienced adverse events: none in the NT, 11 (6." | 6.53 | Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. ( Alberghini, E; Baragetti, I; Buzzi, L; De Silvestri, A; Del Vecchio, L; Ferrario, F; Pani, A; Pozzi, C; Sarcina, C; Scaini, P; Tinelli, C, 2016) |
| "Children with IgA nephropathy showing diffuse (>80%) mesangial proliferation are at high risk for end-stage renal failure (ESRF)." | 3.85 | Long-term results of a randomized controlled trial in childhood IgA nephropathy. ( Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kamei, K; Nakanishi, K; Saito, M; Sako, M; Yoshikawa, N, 2011) |
| "Treatment with prednisolone and azathioprine is beneficial in ameliorating the clinical course of a subset of IgAN patients with heavy proteinuria or impaired renal function." | 3.72 | Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study. ( Ahuja, M; Brown, CB; Davlouros, P; El Nahas, AM; Goumenos, DS; Shortland, JR; Vlachojannis, JG, 2003) |
| " Subsequent to cadaveric renal transplant and 8 years of immunosuppressive treatment with prednisone and azathioprine, the patient developed multiple life-threatening infections." | 3.67 | Hypogammaglobulinemia in a renal transplant recipient with antiglomerular basement membrane disease. ( Hasbargen, J; Rickman, W; Smolin, MR, 1988) |
| "In conclusion, TA-proteinuria is confirmed as one of the best outcome indicators, also in patients with a severe renal insufficiency." | 2.82 | Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy. ( Corghi, E; De Silvestri, A; De Simone, I; Del Vecchio, L; Ferrario, F; Furiani, S; Pani, A; Pozzi, C; Santagostino, G; Sarcina, C; Terraneo, V; Tinelli, C; Visciano, B, 2016) |
| "Among 122 patients with primary IgA nephropathy diagnosed in the 2000-2007 period, 22 fulfilled the inclusion criteria for the study: estimated glomerular filtration rate (eGRF) ≥30 ml/min/1." | 2.76 | Steroids and azathioprine in the treatment of IgA nephropathy. ( Alexopoulos, E; Efstratiadis, G; Ekonomidou, D; Giamalis, P; Liakou, H; Memmos, D; Pantzaki, A; Papagianni, A; Stangou, M; Tsiantoulas, A, 2011) |
| "The optimal treatment for IgA nephropathy (IgAN) remains unknown." | 2.75 | Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. ( Allegri, L; Andrulli, S; Cirami, L; De Cristofaro, V; Del Vecchio, L; Fogazzi, G; Locatelli, F; Pani, A; Pozzi, C; Procaccini, AD; Scaini, P; Vogt, B, 2010) |
| "Treatment with prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease may prevent immunologic renal injury in children with severe IgA nephropathy." | 2.69 | A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. ( Awazu, M; Hattori, S; Honda, M; Iitaka, K; Ito, H; Ito, K; Koitabashi, Y; Matsuyama, S; Nakagawa, K; Nakamura, H; Ninomiya, M; Sakai, T; Seino, Y; Takeda, N; Takekoshi, Y; Yamaoka, K; Yoshikawa, N, 1999) |
| " We used a random-effects model with a Bayesian approach to appraise both renal outcomes and serious adverse effects." | 2.66 | The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis. ( Dong, L; Hu, T; Qin, W; Tan, J; Tang, Y; Tarun, P; Xu, Y; Ye, D; Zhong, Z, 2020) |
| " Thirty-four patients experienced adverse events: none in the NT, 11 (6." | 2.53 | Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. ( Alberghini, E; Baragetti, I; Buzzi, L; De Silvestri, A; Del Vecchio, L; Ferrario, F; Pani, A; Pozzi, C; Sarcina, C; Scaini, P; Tinelli, C, 2016) |
| "We diagnosed highly active IgA nephropathy and initiated treatment with prednisolone and azathioprine." | 1.91 | IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration. ( Hattori, K; Ishikawa, R; Shimizu, R; Tamai, H; Tanaka, S; Terashima, T; Watanabe, T; Yamazaki, M, 2023) |
| "A case of IgA nephropathy (IgAN) associated with Crohn's disease (CD) and preceded Helicobacter pylori (Hp) infection is described." | 1.38 | Is there any association between IgA nephropathy, Crohn's disease and Helicobacter pylori infection? ( Grapsa, E; Michopoulos, S; Mpakirtzi, T; Pipili, C; Sotiropoulou, M, 2012) |
| "The prognosis of children with severe IgA nephropathy showing diffuse mesangial proliferation is poor." | 1.37 | Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy. ( Iijima, K; Kamei, K; Nakanishi, K; Nozu, K; Sasaki, S; Shima, Y; Tanaka, R; Togawa, H; Yoshikawa, N, 2011) |
| "The renal biopsy was performed and IgA nephropathy (type IV) was diagnosed." | 1.35 | [Crohn's disease in association with IgA nephropathy]. ( Choi, YJ; Chung, WC; Kim, HW; Lee, JM; Lee, JR; Lee, KM; Paik, CN; Yang, JM, 2008) |
| "Of 363 patients with IgA nephropathy, 67 patients had vasculitic IgA nephropathy (33 Henoch-Schönlein purpura; 34 IgA)." | 1.35 | Vasculitic IgA nephropathy: prognosis and outcome. ( Adu, D; Harper, L; Howie, AJ; Lepenies, J; Nightingale, P; Pankhurst, T, 2009) |
| "The recurrence of immunoglobulin A nephropathy (IgAN) after renal transplantation has been described in 40% to 50% of cases." | 1.31 | An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. ( Benabdallah, L; Bruneel, MF; Carron, PL; Kreis, H; Morelon, E; Noël, LH; Peraldi, MN; Rerolle, JP, 2002) |
| "These data suggest that IgA nephropathy associated with severe inflammatory and crescenteric change can be effectively and safely treated with a low-cost regime based on oral corticosteroids and cyclophosphamide tailored to a plateau of treatment response in individual patients." | 1.31 | Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. ( Fluck, RJ; Lambie, SH; McIntyre, CW, 2001) |
| " No proteinuria was observed after total dosage of immunosuppressants was increased." | 1.30 | [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)]. ( Hatori, M; Honda, M; Ichimaru, N; Imai, E; Kokado, Y; Kyo, M; Matsumiya, K; Miyamoto, M; Nonomura, N; Okuyama, A; Takahara, S; Takao, T; Yokoyama, K, 1997) |
| "We treated ten children with severe IgA nephropathy (IgAN) [proteinuria greater than 1 g/day, hypertension, renal insufficiency, segmental sclerosis, crescent formation and/or glomerular basement membrane (GBM) deposition of IgA] with prednisone and azathioprine for 1 year." | 1.28 | Treatment of severe IgA nephropathy in children. ( Andreoli, SP; Bergstein, JM, 1989) |
| "Forty seven patients with IgA glomerulonephritis (GN) were studied." | 1.27 | [Clinical, immunological and therapeutic research in mesangial immunoglobulin-A glomerulonephritis]. ( Belovezhdov, N; Robeva, R, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.89) | 18.7374 |
| 1990's | 10 (22.22) | 18.2507 |
| 2000's | 14 (31.11) | 29.6817 |
| 2010's | 15 (33.33) | 24.3611 |
| 2020's | 2 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, K | 2 |
| Shimizu, R | 2 |
| Tanaka, S | 2 |
| Terashima, T | 2 |
| Ishikawa, R | 2 |
| Yamazaki, M | 2 |
| Watanabe, T | 2 |
| Tamai, H | 2 |
| Tan, J | 1 |
| Dong, L | 1 |
| Ye, D | 1 |
| Tang, Y | 1 |
| Hu, T | 1 |
| Zhong, Z | 1 |
| Tarun, P | 1 |
| Xu, Y | 1 |
| Qin, W | 1 |
| Barratt, J | 1 |
| Tang, SCW | 1 |
| Matsuzaki, K | 1 |
| Suzuki, Y | 1 |
| Nakata, J | 1 |
| Sakamoto, N | 1 |
| Horikoshi, S | 1 |
| Kawamura, T | 1 |
| Matsuo, S | 1 |
| Tomino, Y | 1 |
| Stangou, M | 2 |
| Papagianni, A | 2 |
| Bantis, C | 1 |
| Moisiadis, D | 1 |
| Kasimatis, S | 1 |
| Spartalis, M | 1 |
| Pantzaki, A | 2 |
| Efstratiadis, G | 2 |
| Memmos, D | 2 |
| Krisl, JC | 1 |
| Alloway, RR | 1 |
| Shields, AR | 1 |
| Cardi, MA | 1 |
| Woodle, ES | 1 |
| Benck, U | 1 |
| Banas, B | 1 |
| Birck, R | 1 |
| Morales, E | 1 |
| Rabasco, C | 1 |
| Panizo, N | 1 |
| Gutierrez, E | 1 |
| Martinez, MA | 1 |
| Toldos, O | 1 |
| Praga, M | 1 |
| Sarcina, C | 2 |
| Tinelli, C | 2 |
| Ferrario, F | 2 |
| Pani, A | 3 |
| De Silvestri, A | 2 |
| Scaini, P | 2 |
| Del Vecchio, L | 4 |
| Alberghini, E | 1 |
| Buzzi, L | 1 |
| Baragetti, I | 1 |
| Pozzi, C | 4 |
| Visciano, B | 1 |
| De Simone, I | 1 |
| Terraneo, V | 1 |
| Furiani, S | 1 |
| Santagostino, G | 1 |
| Corghi, E | 1 |
| Yoshikawa, N | 6 |
| Lee, JM | 1 |
| Lee, KM | 1 |
| Kim, HW | 1 |
| Chung, WC | 1 |
| Paik, CN | 1 |
| Lee, JR | 1 |
| Choi, YJ | 1 |
| Yang, JM | 1 |
| Pankhurst, T | 1 |
| Lepenies, J | 1 |
| Nightingale, P | 1 |
| Howie, AJ | 1 |
| Adu, D | 1 |
| Harper, L | 1 |
| Shima, Y | 1 |
| Nakanishi, K | 3 |
| Kamei, K | 2 |
| Togawa, H | 1 |
| Nozu, K | 1 |
| Tanaka, R | 1 |
| Sasaki, S | 1 |
| Iijima, K | 3 |
| Andrulli, S | 1 |
| Fogazzi, G | 1 |
| Vogt, B | 1 |
| De Cristofaro, V | 1 |
| Allegri, L | 1 |
| Cirami, L | 1 |
| Procaccini, AD | 1 |
| Locatelli, F | 2 |
| Floege, J | 1 |
| Eitner, F | 1 |
| Ekonomidou, D | 1 |
| Giamalis, P | 1 |
| Liakou, H | 1 |
| Tsiantoulas, A | 1 |
| Alexopoulos, E | 1 |
| Ito, S | 1 |
| Saito, M | 1 |
| Sako, M | 1 |
| Ishikura, K | 1 |
| Hataya, H | 1 |
| Honda, M | 4 |
| Pipili, C | 1 |
| Michopoulos, S | 1 |
| Sotiropoulou, M | 1 |
| Mpakirtzi, T | 1 |
| Grapsa, E | 1 |
| Watanabe, H | 1 |
| Uruma, T | 1 |
| Tsunoda, T | 1 |
| Ishii, H | 1 |
| Tazaki, G | 1 |
| Kondo, T | 1 |
| Benabdallah, L | 1 |
| Rerolle, JP | 1 |
| Peraldi, MN | 1 |
| Noël, LH | 1 |
| Bruneel, MF | 1 |
| Carron, PL | 1 |
| Morelon, E | 1 |
| Kreis, H | 1 |
| Goumenos, DS | 1 |
| Davlouros, P | 1 |
| El Nahas, AM | 1 |
| Ahuja, M | 2 |
| Shortland, JR | 2 |
| Vlachojannis, JG | 1 |
| Brown, CB | 2 |
| Feehally, J | 1 |
| Chandrakantan, A | 1 |
| Ratanapanichkich, P | 1 |
| Said, M | 1 |
| Barker, CV | 1 |
| Julian, BA | 1 |
| Awazu, M | 2 |
| Hattori, S | 2 |
| Ito, H | 3 |
| Belovezhdov, N | 2 |
| Robeva, R | 1 |
| Goumenos, D | 1 |
| Escousse, A | 1 |
| Mousson, C | 1 |
| Santona, L | 1 |
| Zanetta, G | 1 |
| Mounier, J | 1 |
| Tanter, Y | 1 |
| Duperray, F | 1 |
| Rifle, G | 1 |
| Chevet, D | 1 |
| Takao, T | 1 |
| Hatori, M | 1 |
| Ichimaru, N | 1 |
| Nonomura, N | 1 |
| Matsumiya, K | 1 |
| Kokado, Y | 1 |
| Takahara, S | 1 |
| Okuyama, A | 1 |
| Miyamoto, M | 1 |
| Yokoyama, K | 1 |
| Imai, E | 1 |
| Kyo, M | 1 |
| Wardle, EN | 1 |
| Sakai, T | 1 |
| Takekoshi, Y | 1 |
| Ito, K | 1 |
| Iitaka, K | 1 |
| Koitabashi, Y | 1 |
| Yamaoka, K | 1 |
| Nakagawa, K | 1 |
| Nakamura, H | 1 |
| Matsuyama, S | 1 |
| Seino, Y | 1 |
| Takeda, N | 1 |
| Ninomiya, M | 1 |
| Klein, M | 1 |
| Radhakrishnan, J | 1 |
| Appel, G | 1 |
| Manu, MA | 1 |
| Tanabe, K | 2 |
| Ishikawa, N | 2 |
| Tokumoto, T | 2 |
| Oshima, T | 1 |
| Shinmura, H | 1 |
| Harano, M | 1 |
| Otsubo, S | 1 |
| Inui, M | 1 |
| Kanematsu, A | 1 |
| Fuchinoue, S | 1 |
| Toma, H | 2 |
| Risler, T | 1 |
| Braun, N | 1 |
| Barth, C | 1 |
| Suzuki, K | 1 |
| Shimizu, T | 1 |
| Yagisawa, T | 1 |
| Honda, K | 1 |
| Nihei, H | 1 |
| McIntyre, CW | 1 |
| Fluck, RJ | 1 |
| Lambie, SH | 1 |
| Ballardie, FW | 1 |
| Roberts, ISD | 1 |
| Harmankaya, O | 1 |
| Oztürk, Y | 1 |
| Baştürk, T | 1 |
| Obek, A | 1 |
| Kiliçarslan, I | 1 |
| Koselj, M | 1 |
| Rott, T | 1 |
| Andreoli, SP | 1 |
| Bergstein, JM | 1 |
| Smolin, MR | 1 |
| Rickman, W | 1 |
| Hasbargen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)[NCT02647255] | Phase 2/Phase 3 | 10 participants (Actual) | Interventional | 2016-03-31 | Terminated (stopped due to Due to the rarity and rapid progressive course of the disease, patients were less likely to participate in randomization.) | ||
| Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy[NCT00367562] | Phase 4 | 20 participants | Interventional | 1996-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for azathioprine and Berger Disease
| Article | Year |
|---|---|
The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis.
Topics: Adult; Azathioprine; Clinical Trials as Topic; Drug Combinations; Female; Glomerulonephritis, IGA; G | 2020 |
Treatment of IgA Nephropathy: Evolution Over Half a Century.
Topics: Adrenal Cortex Hormones; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2018 |
[Primary and secondary glomerular diseases].
Topics: Abatacept; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Glomerul | 2014 |
Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; | 2016 |
[Treatment of childhood IgA nephropathy].
Topics: Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Glomeruloneph | 2008 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
Cyclosporine treatment of glomerular diseases.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonep | 1999 |
The patient with IgA glomerulonephritis--what is the role of steroid treatment?
Topics: Adrenal Cortex Hormones; Azathioprine; Glomerulonephritis, IGA; Humans; Italy; Kidney Failure, Chron | 1999 |
9 trials available for azathioprine and Berger Disease
| Article | Year |
|---|---|
Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Creatinine; Drug Therapy, Combinatio | 2016 |
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Antihypertensive Agents; Azathioprine; Blood Pressure; Drug Therapy, | 2010 |
Steroids and azathioprine in the treatment of IgA nephropathy.
Topics: Adult; Azathioprine; Fatty Acids, Unsaturated; Female; Glomerular Filtration Rate; Glomerulonephriti | 2011 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Topics: Azathioprine; Child; Dipyridamole; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; P | 2006 |
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Topics: Adolescent; Azathioprine; Blood Urea Nitrogen; Child; Dipyridamole; Drug Therapy, Combination; Glome | 1999 |
The patient with IgA glomerulonephritis--what is the role of steroid treatment?
Topics: Adrenal Cortex Hormones; Azathioprine; Glomerulonephritis, IGA; Humans; Italy; Kidney Failure, Chron | 1999 |
Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Topics: Adult; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Glomerulonephri | 1999 |
Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
Topics: Adult; Azathioprine; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Erythr | 2002 |
30 other studies available for azathioprine and Berger Disease
| Article | Year |
|---|---|
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
Nationwide survey on current treatments for IgA nephropathy in Japan.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Chi | 2013 |
Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Azathioprine; Biomarkers; Biopsy; Creatinine; Cytokin | 2013 |
Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
Topics: Abatacept; Adult; Azathioprine; Biopsy; Boronic Acids; Bortezomib; Calcineurin Inhibitors; Cyclospor | 2014 |
Mesangial nephropathy and anti-synthetase syndrome: An odd association.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Dyspnea; Edem | 2015 |
[Crohn's disease in association with IgA nephropathy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antimetabo | 2008 |
Vasculitic IgA nephropathy: prognosis and outcome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Blood Pre | 2009 |
Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Topics: Anti-Inflammatory Agents; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combinati | 2011 |
Combined immunosuppression in high-risk patients with IgA nephropathy?
Topics: Adrenal Cortex Hormones; Azathioprine; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; I | 2010 |
Is there any association between IgA nephropathy, Crohn's disease and Helicobacter pylori infection?
Topics: Azathioprine; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephritis, IGA; | 2012 |
Bronchial asthma developing after 15 years of immunosuppressive treatment following renal transplantation.
Topics: Adult; Asthma; Azathioprine; Cyclosporine; Female; Glomerulonephritis, IGA; Humans; Immunosuppressiv | 2012 |
An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.
Topics: Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis; Glomerulonephritis, IGA; Gra | 2002 |
Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Topics: Adult; Azathioprine; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up St | 2003 |
Treating IgA Nephropathy - Who, When and How?.
Topics: Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclophospha | 2003 |
Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Topics: Adult; Azathioprine; Glomerulonephritis, IGA; Graft Survival; Humans; Immunosuppressive Agents; Kidn | 2005 |
[Clinical, immunological and therapeutic research in mesangial immunoglobulin-A glomerulonephritis].
Topics: Acenocoumarol; Adolescent; Adult; Antigen-Antibody Complex; Azathioprine; Chronic Disease; Complemen | 1984 |
Can immunosuppressive drugs slow the progression of IgA nephropathy?
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Disease Progression; Female; Glomerulonephritis, IGA; | 1995 |
Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study.
Topics: Adult; Azathioprine; Erythrocytes; Female; Glomerulonephritis, IGA; Homozygote; Humans; Kidney Trans | 1995 |
[A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
Topics: Adult; Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis, IGA; Graft Rejection; | 1997 |
IgA nephropathy: to treat or not to treat?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cytotoxins; Glomerulonephritis, IGA; Humans; | 1998 |
Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Topics: ABO Blood-Group System; Adult; Azathioprine; Blood Group Incompatibility; Chronic Disease; Cyclospor | 1999 |
[Treatment of IGA nephritis].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Azathioprine; Child; Controlled Clinical Trials as Topi | 2000 |
[Early treatment of IgA nephritis is indicated by prognostic factors].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azathioprine; Cycl | 2000 |
Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; | 2000 |
Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Biopsy; Creatinine; Cyclophosphamide; D | 2001 |
Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Topics: Adolescent; Adult; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administrati | 2002 |
Immunoglobulin A nephropathy in renal transplant recipients.
Topics: Adult; Azathioprine; Biopsy; Cyclosporine; Female; Fluorescent Antibody Technique; Follow-Up Studies | 1992 |
Treatment of severe IgA nephropathy in children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Female; Fluorescent Antibody Technique; Follow-Up | 1989 |
Hypogammaglobulinemia in a renal transplant recipient with antiglomerular basement membrane disease.
Topics: Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Azathioprine; Basement Membran | 1988 |
[Differentiated pathogenetic therapy of glomerulonephritis].
Topics: Adrenal Cortex Hormones; Anticoagulants; Azathioprine; Chronic Disease; Drug Evaluation; Drug Therap | 1987 |